{"id":1210,"date":"2020-03-25T15:24:44","date_gmt":"2020-03-25T14:24:44","guid":{"rendered":"https:\/\/leo-foundation.org.bluebird.pw\/da\/?p=1210"},"modified":"2020-09-30T15:44:56","modified_gmt":"2020-09-30T13:44:56","slug":"leo-fondets-aarsrapport-2019","status":"publish","type":"post","link":"https:\/\/leo-foundation.org.bluebird.pw\/da\/2020\/03\/25\/leo-fondets-aarsrapport-2019\/","title":{"rendered":"LEO Fondets \u00c5rsrapport 2019"},"content":{"rendered":"\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><strong>H\u00f8jt afkast p\u00e5 DKK 2,3 milliarder p\u00e5 LEO Fondets investeringer og en betydelig fremgang i LEO Pharmas transition mod innovative behandlinger af hudsygdomme.<\/strong><\/p>\n\n\n\n<p>Hovedpunkterne i \u00e5rsregnskabet er:<\/p>\n\n\n\n<p><strong>LEO Pharma<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>LEO Group pr\u00e6sterede i 2019 et samlet overskud p\u00e5 DKK 389 millioner, hvilket er en tilbagegang i forhold til&nbsp;2018, hvor overskuddet var p\u00e5 DKK 708 millioner. Tilbagegangen skyldes \u00f8gede investeringer i forskning og udvikling samt engangsindt\u00e6gter i 2018.<\/li><li>LEO Pharma havde salgsindt\u00e6gter p\u00e5 DKK 10,8 milliarder, hvilket repr\u00e6senterer en v\u00e6kst p\u00e5 7 % eksklusiv frasalg, valutaeffekter og andre engangseffekter. <\/li><li>LEO Pharma \u00f8gede indtjeningen (EBITDA) p\u00e5 sin etablerede produktportef\u00f8lje fra 27 % til 31 %, mens investeringer i forskning og udvikling steg til 23% af oms\u00e6tningen. <\/li><li>Tralokinumab, en innovativ biologisk l\u00e6gemiddelkandidat under udvikling til behandling af moderat til sv\u00e6r eksem, n\u00e5ede de prim\u00e6re og sekund\u00e6re effektm\u00e5l i de kritiske fase 3 fors\u00f8g, og selskabet kan dermed forberede indsendelse af registreringsans\u00f8gninger til myndighederne i USA, Europa og Japan.<\/li><li>Med aktiviteterne i 2019 har LEO Pharma yderligere styrket sin allerede attraktive pipeline af l\u00e6gemiddelkandidater til det voksende marked for behandlinger mod hudsygdomme.<\/li><\/ul>\n\n\n\n<p><strong>LEO Fondet<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>LEO Fondets finansielle investeringsaktiviteter gav et betydeligt afkast p\u00e5 DKK 2,3 milliarder svarende til 14,9 % og \u00f8gede dermed Fondets samlede investeringsaktiver til DKK 15,2 milliarder. Afkastet p\u00e5 investeringerne var en fremgang i forhold til 2018, hvor afkastet var p\u00e5 -3,1 % svarende til DKK -519 millioner.<\/li><li>LEO Fondet bevilgede uddelinger og priser for et samlet bel\u00f8b p\u00e5 DKK 79 millioner, mens de samlede udbetalinger (inklusive milep\u00e6lsbetalinger til tidligere \u00e5rs uddelinger) steg til DKK 100 millioner. 63 % af LEO Fondets samlede bevillinger i 2019 blev givet til forskere i Danmark.<\/li><li>LEO Fondet udpegede i 2019 to nye medlemmer til Fondets bestyrelse, Anja Boisen, professor p\u00e5 DTU og Karin Hamberg, Senior Vice President i Lundbeck A\/S.<\/li><\/ul>\n\n\n\n<h4 class=\"wp-block-heading\"><\/h4>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link\" href=\"https:\/\/leo-foundation.org.bluebird.pw\/da\/nyheder-presse\/publikationer\/\">Download \u00c5rsrapport 2019<\/a><\/div>\n<\/div>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>H\u00f8jt afkast p\u00e5 DKK 2,3 milliarder p\u00e5 LEO Fondets investeringer og en betydelig fremgang i LEO Pharmas transition mod innovative behandlinger af hudsygdomme. Hovedpunkterne i \u00e5rsregnskabet er: LEO Pharma LEO Group pr\u00e6sterede i 2019 et samlet overskud p\u00e5 DKK 389 millioner, hvilket er en tilbagegang i forhold til&nbsp;2018, hvor overskuddet var p\u00e5 DKK 708 millioner. &hellip; <a href=\"https:\/\/leo-foundation.org.bluebird.pw\/da\/2020\/03\/25\/leo-fondets-aarsrapport-2019\/\">Fortsat<\/a><\/p>\n","protected":false},"author":4,"featured_media":749,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1210","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nyheder"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>LEO Fondets \u00c5rsrapport 2019 - LEO Fondet<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"da_DK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LEO Fondets \u00c5rsrapport 2019 - LEO Fondet\" \/>\n<meta property=\"og:description\" content=\"H\u00f8jt afkast p\u00e5 DKK 2,3 milliarder p\u00e5 LEO Fondets investeringer og en betydelig fremgang i LEO Pharmas transition mod innovative behandlinger af hudsygdomme. Hovedpunkterne i \u00e5rsregnskabet er: LEO Pharma LEO Group pr\u00e6sterede i 2019 et samlet overskud p\u00e5 DKK 389 millioner, hvilket er en tilbagegang i forhold til&nbsp;2018, hvor overskuddet var p\u00e5 DKK 708 millioner. &hellip; Fortsat\" \/>\n<meta property=\"og:url\" content=\"https:\/\/leo-foundation.org.bluebird.pw\/da\/2020\/03\/25\/leo-fondets-aarsrapport-2019\/\" \/>\n<meta property=\"og:site_name\" content=\"LEO Fondet\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-25T14:24:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-09-30T13:44:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/leo-foundation.org.bluebird.pw\/da\/wp-content\/uploads\/2020\/09\/Forside-2019-e1601473309406.png\" \/>\n\t<meta property=\"og:image:width\" content=\"717\" \/>\n\t<meta property=\"og:image:height\" content=\"403\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"signe\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skrevet af\" \/>\n\t<meta name=\"twitter:data1\" content=\"signe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimeret l\u00e6setid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/2020\\\/03\\\/25\\\/leo-fondets-aarsrapport-2019\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/2020\\\/03\\\/25\\\/leo-fondets-aarsrapport-2019\\\/\"},\"author\":{\"name\":\"signe\",\"@id\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/#\\\/schema\\\/person\\\/cea9bf7443512a524b6a064ad4900bcc\"},\"headline\":\"LEO Fondets \u00c5rsrapport 2019\",\"datePublished\":\"2020-03-25T14:24:44+00:00\",\"dateModified\":\"2020-09-30T13:44:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/2020\\\/03\\\/25\\\/leo-fondets-aarsrapport-2019\\\/\"},\"wordCount\":295,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/2020\\\/03\\\/25\\\/leo-fondets-aarsrapport-2019\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/Forside-2019-e1601473309406.png\",\"articleSection\":[\"Nyheder\"],\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/2020\\\/03\\\/25\\\/leo-fondets-aarsrapport-2019\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/2020\\\/03\\\/25\\\/leo-fondets-aarsrapport-2019\\\/\",\"url\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/2020\\\/03\\\/25\\\/leo-fondets-aarsrapport-2019\\\/\",\"name\":\"LEO Fondets \u00c5rsrapport 2019 - LEO Fondet\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/2020\\\/03\\\/25\\\/leo-fondets-aarsrapport-2019\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/2020\\\/03\\\/25\\\/leo-fondets-aarsrapport-2019\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/Forside-2019-e1601473309406.png\",\"datePublished\":\"2020-03-25T14:24:44+00:00\",\"dateModified\":\"2020-09-30T13:44:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/#\\\/schema\\\/person\\\/cea9bf7443512a524b6a064ad4900bcc\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/2020\\\/03\\\/25\\\/leo-fondets-aarsrapport-2019\\\/#breadcrumb\"},\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/2020\\\/03\\\/25\\\/leo-fondets-aarsrapport-2019\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/2020\\\/03\\\/25\\\/leo-fondets-aarsrapport-2019\\\/#primaryimage\",\"url\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/Forside-2019-e1601473309406.png\",\"contentUrl\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/Forside-2019-e1601473309406.png\",\"width\":717,\"height\":403},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/2020\\\/03\\\/25\\\/leo-fondets-aarsrapport-2019\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Forside\",\"item\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LEO Fondets \u00c5rsrapport 2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/#website\",\"url\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/\",\"name\":\"LEO Fondet\",\"description\":\"Endnu en WordPress-blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"da-DK\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/leo-foundation.org.bluebird.pw\\\/da\\\/#\\\/schema\\\/person\\\/cea9bf7443512a524b6a064ad4900bcc\",\"name\":\"signe\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bbdf2b5401cc1716c74fa555bf518a86ef8f041c879b444886de237aa0e61ca7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bbdf2b5401cc1716c74fa555bf518a86ef8f041c879b444886de237aa0e61ca7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bbdf2b5401cc1716c74fa555bf518a86ef8f041c879b444886de237aa0e61ca7?s=96&d=mm&r=g\",\"caption\":\"signe\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LEO Fondets \u00c5rsrapport 2019 - LEO Fondet","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"da_DK","og_type":"article","og_title":"LEO Fondets \u00c5rsrapport 2019 - LEO Fondet","og_description":"H\u00f8jt afkast p\u00e5 DKK 2,3 milliarder p\u00e5 LEO Fondets investeringer og en betydelig fremgang i LEO Pharmas transition mod innovative behandlinger af hudsygdomme. Hovedpunkterne i \u00e5rsregnskabet er: LEO Pharma LEO Group pr\u00e6sterede i 2019 et samlet overskud p\u00e5 DKK 389 millioner, hvilket er en tilbagegang i forhold til&nbsp;2018, hvor overskuddet var p\u00e5 DKK 708 millioner. &hellip; Fortsat","og_url":"https:\/\/leo-foundation.org.bluebird.pw\/da\/2020\/03\/25\/leo-fondets-aarsrapport-2019\/","og_site_name":"LEO Fondet","article_published_time":"2020-03-25T14:24:44+00:00","article_modified_time":"2020-09-30T13:44:56+00:00","og_image":[{"width":717,"height":403,"url":"https:\/\/leo-foundation.org.bluebird.pw\/da\/wp-content\/uploads\/2020\/09\/Forside-2019-e1601473309406.png","type":"image\/png"}],"author":"signe","twitter_card":"summary_large_image","twitter_misc":{"Skrevet af":"signe","Estimeret l\u00e6setid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/leo-foundation.org.bluebird.pw\/da\/2020\/03\/25\/leo-fondets-aarsrapport-2019\/#article","isPartOf":{"@id":"https:\/\/leo-foundation.org.bluebird.pw\/da\/2020\/03\/25\/leo-fondets-aarsrapport-2019\/"},"author":{"name":"signe","@id":"https:\/\/leo-foundation.org.bluebird.pw\/da\/#\/schema\/person\/cea9bf7443512a524b6a064ad4900bcc"},"headline":"LEO Fondets \u00c5rsrapport 2019","datePublished":"2020-03-25T14:24:44+00:00","dateModified":"2020-09-30T13:44:56+00:00","mainEntityOfPage":{"@id":"https:\/\/leo-foundation.org.bluebird.pw\/da\/2020\/03\/25\/leo-fondets-aarsrapport-2019\/"},"wordCount":295,"commentCount":0,"image":{"@id":"https:\/\/leo-foundation.org.bluebird.pw\/da\/2020\/03\/25\/leo-fondets-aarsrapport-2019\/#primaryimage"},"thumbnailUrl":"https:\/\/leo-foundation.org.bluebird.pw\/da\/wp-content\/uploads\/2020\/09\/Forside-2019-e1601473309406.png","articleSection":["Nyheder"],"inLanguage":"da-DK","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/leo-foundation.org.bluebird.pw\/da\/2020\/03\/25\/leo-fondets-aarsrapport-2019\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/leo-foundation.org.bluebird.pw\/da\/2020\/03\/25\/leo-fondets-aarsrapport-2019\/","url":"https:\/\/leo-foundation.org.bluebird.pw\/da\/2020\/03\/25\/leo-fondets-aarsrapport-2019\/","name":"LEO Fondets \u00c5rsrapport 2019 - LEO Fondet","isPartOf":{"@id":"https:\/\/leo-foundation.org.bluebird.pw\/da\/#website"},"primaryImageOfPage":{"@id":"https:\/\/leo-foundation.org.bluebird.pw\/da\/2020\/03\/25\/leo-fondets-aarsrapport-2019\/#primaryimage"},"image":{"@id":"https:\/\/leo-foundation.org.bluebird.pw\/da\/2020\/03\/25\/leo-fondets-aarsrapport-2019\/#primaryimage"},"thumbnailUrl":"https:\/\/leo-foundation.org.bluebird.pw\/da\/wp-content\/uploads\/2020\/09\/Forside-2019-e1601473309406.png","datePublished":"2020-03-25T14:24:44+00:00","dateModified":"2020-09-30T13:44:56+00:00","author":{"@id":"https:\/\/leo-foundation.org.bluebird.pw\/da\/#\/schema\/person\/cea9bf7443512a524b6a064ad4900bcc"},"breadcrumb":{"@id":"https:\/\/leo-foundation.org.bluebird.pw\/da\/2020\/03\/25\/leo-fondets-aarsrapport-2019\/#breadcrumb"},"inLanguage":"da-DK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/leo-foundation.org.bluebird.pw\/da\/2020\/03\/25\/leo-fondets-aarsrapport-2019\/"]}]},{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/leo-foundation.org.bluebird.pw\/da\/2020\/03\/25\/leo-fondets-aarsrapport-2019\/#primaryimage","url":"https:\/\/leo-foundation.org.bluebird.pw\/da\/wp-content\/uploads\/2020\/09\/Forside-2019-e1601473309406.png","contentUrl":"https:\/\/leo-foundation.org.bluebird.pw\/da\/wp-content\/uploads\/2020\/09\/Forside-2019-e1601473309406.png","width":717,"height":403},{"@type":"BreadcrumbList","@id":"https:\/\/leo-foundation.org.bluebird.pw\/da\/2020\/03\/25\/leo-fondets-aarsrapport-2019\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Forside","item":"https:\/\/leo-foundation.org.bluebird.pw\/da\/"},{"@type":"ListItem","position":2,"name":"LEO Fondets \u00c5rsrapport 2019"}]},{"@type":"WebSite","@id":"https:\/\/leo-foundation.org.bluebird.pw\/da\/#website","url":"https:\/\/leo-foundation.org.bluebird.pw\/da\/","name":"LEO Fondet","description":"Endnu en WordPress-blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/leo-foundation.org.bluebird.pw\/da\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"da-DK"},{"@type":"Person","@id":"https:\/\/leo-foundation.org.bluebird.pw\/da\/#\/schema\/person\/cea9bf7443512a524b6a064ad4900bcc","name":"signe","image":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/secure.gravatar.com\/avatar\/bbdf2b5401cc1716c74fa555bf518a86ef8f041c879b444886de237aa0e61ca7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bbdf2b5401cc1716c74fa555bf518a86ef8f041c879b444886de237aa0e61ca7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bbdf2b5401cc1716c74fa555bf518a86ef8f041c879b444886de237aa0e61ca7?s=96&d=mm&r=g","caption":"signe"}}]}},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"LEO Fondet","distributor_original_site_url":"https:\/\/leo-foundation.org.bluebird.pw\/da","push-errors":false,"_links":{"self":[{"href":"https:\/\/leo-foundation.org.bluebird.pw\/da\/wp-json\/wp\/v2\/posts\/1210","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/leo-foundation.org.bluebird.pw\/da\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/leo-foundation.org.bluebird.pw\/da\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/leo-foundation.org.bluebird.pw\/da\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/leo-foundation.org.bluebird.pw\/da\/wp-json\/wp\/v2\/comments?post=1210"}],"version-history":[{"count":4,"href":"https:\/\/leo-foundation.org.bluebird.pw\/da\/wp-json\/wp\/v2\/posts\/1210\/revisions"}],"predecessor-version":[{"id":1219,"href":"https:\/\/leo-foundation.org.bluebird.pw\/da\/wp-json\/wp\/v2\/posts\/1210\/revisions\/1219"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/leo-foundation.org.bluebird.pw\/da\/wp-json\/wp\/v2\/media\/749"}],"wp:attachment":[{"href":"https:\/\/leo-foundation.org.bluebird.pw\/da\/wp-json\/wp\/v2\/media?parent=1210"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/leo-foundation.org.bluebird.pw\/da\/wp-json\/wp\/v2\/categories?post=1210"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/leo-foundation.org.bluebird.pw\/da\/wp-json\/wp\/v2\/tags?post=1210"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}